Related references
Note: Only part of the references are listed.The sigma-1 receptor mediates the beneficial effects of pridopidine in a mouse model of Huntington disease
Daniel Ryskamp et al.
NEUROBIOLOGY OF DISEASE (2017)
Early pridopidine treatment improves behavioral and transcriptional deficits in YAC128 Huntington disease mice
Marta Garcia-Miralles et al.
JCI INSIGHT (2017)
Phosphorylation Signals in Striatal Medium Spiny Neurons
Taku Nagai et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
Impaired TrkB Signaling Underlies Reduced BDNF-Mediated Trophic Support of Striatal Neurons in the R6/2 Mouse Model of Huntington's Disease
Khanh Q. Nguyen et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2016)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
Pridopidine selectively occupies sigma-1 rather than dopamine D2 receptors at behaviorally active doses
Kristoffer Sahlholm et al.
PSYCHOPHARMACOLOGY (2015)
The Role of H3K4me3 in Transcriptional Regulation Is Altered in Huntington's Disease
Xianjun Dong et al.
PLOS ONE (2015)
Npas4 Regulates Excitatory-Inhibitory Balance within Neural Circuits through Cell-Type-Specific Gene Programs
Ivo Spiegel et al.
CELL (2014)
Dexamethasone induces heat shock response and slows down disease progression in mouse and fly models of Huntingtons disease
Megha Maheshwari et al.
HUMAN MOLECULAR GENETICS (2014)
Bidirectional Control of Postsynaptic Density-95 (PSD-95) Clustering by Huntingtin
Matthew P. Parsons et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Impaired TrkB Receptor Signaling Underlies Corticostriatal Dysfunction in Huntington's Disease
Joshua L. Plotkin et al.
NEURON (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
A gene signature based method for identifying subtypes and subtype-specific drivers in cancer with an application to medulloblastoma
Peikai Chen et al.
BMC BIOINFORMATICS (2013)
The dopaminergic stabilizer pridopidine decreases expression of L-DOPA-induced locomotor sensitisation in the rat unilateral 6-OHDA model
Henrik Ponten et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Regulation of Feedback between Protein Kinase A and the Proteasome System Worsens Huntington's Disease
Jiun-Tsai Lin et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
A Randomized, Double-Blind, Placebo-Controlled Trial of Pridopidine in Huntington's Disease
Karl Kieburtz et al.
MOVEMENT DISORDERS (2013)
Dopamine D1 Receptors, Regulation of Gene Expression in the Brain, and Neurodegeneration
Jean Lud Cadet et al.
CNS & Neurological Disorders-Drug Targets (2012)
PSD-95 expression controls L-DOPA dyskinesia through dopamine D1 receptor trafficking
Gregory Porras et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial
Justo Garcia de Yebenes et al.
LANCET NEUROLOGY (2011)
Altered balance of activity in the striatal direct and indirect pathways in mouse models of Huntington's disease
Veronique M. Andre et al.
FRONTIERS IN SYSTEMS NEUROSCIENCE (2011)
edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
Mark D. Robinson et al.
BIOINFORMATICS (2010)
The dopaminergic stabilizers pridopidine (ACR16) and (-)-OSU6162 display dopamine D2 receptor antagonism and fast receptor dissociation properties
Tino Dyhring et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
In vivo pharmacology of the dopaminergic stabilizer pridopidine
Henrik Ponten et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
BDNF Overexpression in the Forebrain Rescues Huntington's Disease Phenotypes in YAC128 Mice
Yuxiang Xie et al.
JOURNAL OF NEUROSCIENCE (2010)
Corticostriatal circuit dysfunction in Huntington's disease: intersection of glutamate, dopamine and calcium
Benjamin Ray Miller et al.
FUTURE NEUROLOGY (2010)
Increased Hypothalamic-Pituitary-Adrenal Axis Activity in Huntington's Disease
N. Ahmad Aziz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
CREB is a key regulator of striatal vulnerability in chemical and genetic models of Huntington's disease
Yun-Sik Choi et al.
NEUROBIOLOGY OF DISEASE (2009)
GPR3 Receptor, a Novel Actor in the Emotional-Like Responses
Olga Valverde et al.
PLOS ONE (2009)
Short-Term Striatal Gene Expression Responses to Brain-Derived Neurotrophic Factor Are Dependent on MEK and ERK Activation
Ozgun Gokce et al.
PLOS ONE (2009)
Huntingtin phosphorylation acts as a molecular switch for anterograde/retrograde transport in neurons
Emilie Colin et al.
EMBO JOURNAL (2008)
Large-scale analysis of glucocorticoid target genes in rat hypothalamus
H. Sato et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Inhibition of the dopamine D1 receptor signaling by PSD-95
Jingping Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements
Leming Shi et al.
NATURE BIOTECHNOLOGY (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules
LR Gauthier et al.
CELL (2004)
Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease
EJ Slow et al.
HUMAN MOLECULAR GENETICS (2003)
Striatal gene expression of RGS2 and RGS4 is specifically mediated by dopamine D1 and D2 receptors: clues for RGS2 and RGS4 functions
JM Taymans et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice
S Gines et al.
HUMAN MOLECULAR GENETICS (2003)
Polyglutamine-expanded Huntingtin promotes sensitization of N-methyl-D-aspartate receptors via post-synaptic density 95
Y Sun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice
JA Bibb et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
